Status:

RECRUITING

Is There an Association Between Quadriceps Strength and Different Markers of Fragility in Patients With Cirrhosis?

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Cirrhosis

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Physical frailty and malnutrition are important factors in morbidity and mortality in patients with cirrhosis. No study has assessed the validity of Liver Frailty Index (LFI) against reference measure...

Detailed Description

Secondary objective: compare the different strength parameters of patients with cirrhosis (strength endurance, rate of strength development) with healthy subjects.

Eligibility Criteria

Inclusion

  • SUBJECT :
  • with a diagnosis of liver cirrhosis (regardless of cirrhosis stage and etiology)
  • under the care of a physician practising in the University Hospital Estaing in Clermont-Ferrand
  • affiliated to the french social security system

Exclusion

  • SUBJECT:
  • with hepatocellular carcinoma
  • with HIV infection
  • with hepatic encephalopathy grade ≥ 2
  • with cognitive dysfunction
  • with contraindication for physical activity
  • with knee pain/knee disorders
  • pregnant or breastfeeding
  • under protective supervision (guardianship, curatorship, protection of the court)
  • Inclusion Criteria for healthy volonteers:
  • male subjects aged 52 to 62
  • female subjects aged 42 to 60
  • BMI between 20 and 30 kg/m2
  • no musculoskeletal problems limiting physical activity
  • level of physical activity \< 3 hours per week
  • affiliated to the french social security system
  • Exclusion Criteria for healthy volonteers:
  • medical or surgical history deemed incompatible with the trial by the investigator
  • simultaneous participation in a trial involving a drug or medical device, or period of exclusion from such a trial
  • participants protected by law (under guardianship, conservatorship, or protection of the court)

Key Trial Info

Start Date :

November 20 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06133127

Start Date

November 20 2023

End Date

December 1 2026

Last Update

December 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU clermont-ferrand

Clermont-Ferrand, France